Spamdex - Spam Archive

Report spam

Send in your spam and get the offenders listed

Create a rule in outlook or simply forward the spam you receive to questions@spamdex.co.uk

Also in kaiserhealthnews.org

KHN First Edition: February 14, 2017

KHN

First Edition

Tuesday, February 14, 2017
Check Kaiser Health News online for the latest headlines

Today's early morning highlights from the major news organizations.

Kaiser Health News: A Deep Dive Into 4 GOP Talking Points On Health Care
Julie Rovner reports: "Republicans leaders have a lengthy list of talking points about the shortcomings of the health law. Shortly before his inauguration last month, President Donald Trump said that it “is a complete and total disaster. It’s imploding as we sit.” And they can point to a host of issues, including premium increases averaging more than 20 percent this year, a drop in the number of insurers competing on the Affordable Care Act marketplaces and rising consumer discontent with high deductibles and limited doctor networks. Yet a careful analysis of some of the GOP’s talking points show a much more nuanced situation and suggest that the political fights over the law may have contributed to some of its problems." (Rovner, 2/14)

Kaiser Health News: Drugmaker Marathon ‘Pausing’ Delivery Of $89,000-A-Year Muscular Dystrophy Drug
Sarah Jane Tribble and Sydney Lupkin report: "In a surprise move Monday, Marathon Pharmaceuticals told patient advocates that it would “pause” the launch of its drug Emflaza because of pricing concerns expressed by patients and advocacy groups.The drugmaker had announced an $89,000 annual price tag for its newly approved drug last week but patients and lawmakers immediately cried foul." (Tribble and Lupkin, 2/13)

Kaiser Health News: Former FDA Chief Cites 5 Things To Watch On Drug Approvals, And Keeping Drugs Safe
Sydney Lupkin and Sarah Jane Tribble report: "The just-departed commissioner of the Food and Drug Administration has concerns about plans to speed up drug approvals and dramatically reduce regulations at the agency, as advocated recently by President Donald Trump. Dr. Robert Califf, who stepped down last month, shared his thoughts about keeping Americans safe — and making sure drugs actually work — after about a year overseeing the federal agency." (Lupkin and Tribble, 2/14)

Kaiser Health News: Judge Upends Effort To Limit Charity Funding For Kidney Patients’ Insurance
Michelle Andrews reports: "Every night, Jason Early attaches a catheter in his chest to a machine by his bed that, over the course of nine hours while he sleeps, removes his blood from his body, cleanses it and returns it because his kidneys are no longer able to do the job. It’s been about 18 months since the 28-year-old Dallas resident started getting dialysis after his kidneys failed as a complication from the Type 1 diabetes with which he was diagnosed as a child. Like many patients with end-stage renal disease, Early, who is completing a bachelor’s degree in finance at the University of North Texas at Dallas, turned to a charity for financial assistance to cover his health insurance costs." (Andrews, 2/14)

USA Today: Senate Confirms David Shulkin As Veterans Affairs Secretary
The Senate unaminously confirmed Trump nominee David Shulkin to be secretary of Veterans Affairs Monday night. Shulkin, the lone holdover from the Obama administration among President Trump’s Cabinet picks, has been the VA undersecretary for health since July 2015 and has not drawn the harsh opposition from Democrats that other Trump nominees have faced. (Slack, 2/13)

The Associated Press: Senate Easily Confirms Trump Pick Of Shulkin As VA Secretary
Senators voted 100-0 to approve the former Obama administration official, who was the VA's top health official since 2015, in a rare show of bipartisanship amid partisan rancor over Trump's other nominees. Shulkin secured the backing of Senate Democrats after pledging at his confirmation hearing to always protect veterans' interests, even if it meant disagreeing at times with Trump. (2/13)

The Washington Post: Shulkin Unanimously Confirmed To Head Veterans Affairs
The 57-year-old Pennsylvania native will run the second-largest federal agency after serving 18 months as undersecretary for health in charge of VA’s sprawling medical system, which takes care of nearly 9 million veterans a year. After a long search for a leader who could turn around a system Trump denounced on the campaign trail as a tragic failure, the president surprised critics by turning inside rather than outside for a VA leader. (Rein, 2/13)

NPR: Senate Confirms First Nonveteran To Lead VA
Over the past two years, Shulkin oversaw the implementation of the Veterans Access Choice and Accountability Act, a $16 billion congressional fix for the long wait times for veterans seeking care. But an NPR investigation found that the fix itself is broken: A $10 billion program to help veterans get care in the private sector resulted in mountains of red tape, and a $2.5 billion hiring program didn't significantly increase the hiring of new doctors and nurses inside the VA. (Lawrence, 2/13)

Politico: Veterans Affairs Secretary Confirmed 100-0
"Veterans are very fortunate to have Dr. Shulkin voluntarily stay in what has evolved into the most scrutinized and criticized position in the country," Veterans of Foreign Wars National Commander Brian Duffy said in a statement. "And it should be," he added. The conservative Concerned Veterans for America, which has pushed for veterans to obtain greater health care from the private sector and has criticized the VA for not holding problem employees accountable, said Monday it was "encouraged" Shulkin had "acknowledged systemic failures within the VA and the need for transformational reforms to fix them." (O'Brien, 2/13)

The New York Times: Angry Town Hall Meetings On Health Care Law, And Few Answers
Michelle Roelandts had a question for her congressman: If the Affordable Care Act and its premium subsidies were repealed, what would happen when her daughter turns 26 this year and needs to get her own health insurance while attending law school? Representative Jim Sensenbrenner, a durable Wisconsin Republican who has served in the House since 1979, had little to offer in response. “If I could give you an answer today, I would, but I can’t,” Mr. Sensenbrenner said at a town-hall-style meeting on Saturday, where about 70 people packed a room at the Pewaukee Public Library. (Kaplan, 2/13)

The Wall Street Journal: Legal Challenges Could Leave U.S. On The Hook For Obamacare ‘Risk Corridor’ Payments
A recent ruling by a federal judge that the U.S. government must pay more than $200 million to an Oregon insurer could mean serious financial and political headaches for the Trump administration in the months to come. The decision last week by a judge on the U.S. Court of Federal Claims requires the government to pay Moda Health Plan Inc. money it said it was owed under an Affordable Care Act provision intended to cover insurers financial shortfalls. (Armour, 2/13)

Politico: Conservatives Balking At GOP Leadership's Obamacare Plans
House conservatives — anxious that the GOP’s effort to end Obamacare is getting bogged down in the fight over what a replacement should look like — are plotting a major push to repeal the law immediately without simultaneously approving an alternative. The House Freedom Caucus and a number of Republican Study Committee members this week will urge Speaker Paul Ryan (R-Wis.) and his lieutenants to forego their plan to add replacement provisions to a repeal bill, dubbed “repeal-plus.” Instead, they want to approve the same standalone repeal bill that Congress sent to President Barack Obama in 2016. (Bade, 2/13)

The Washington Post: The Strange Tale Of How A False 2009 Obamacare Claim Ended Up In A Viral 2017 Video
Bill Akins achieved his 15 minutes of fame — and, he says, death threats — after a clip of him making this statement at a Florida town hall when viral. The audience immediately hooted him down, and he responded by saying, “Okay, children. All right, children.” In 2009, former Alaska governor Sarah Palin first promoted the idea that the emerging law contained death panels, referring to a provision that would allow Medicare to pay for doctor’s appointments for patients to discuss living wills and other end-of-life issues. (Kessler, 2/14)

The Associated Press: Company Announces Pause For Drug After Price Criticism
Marathon Pharmaceuticals announced Monday that it will temporarily halt the rollout of a drug to treat genetic muscle deterioration just hours after two members of Congress expressed outrage that the company planned to charge $89,000 a year for a drug that's widely available abroad for about $1,000 a year. Sen. Bernie Sanders, I-Vt., and Rep. Elijah Cummings, D-Md., urged the company earlier in the day to lower the drug's price. (2/13)

The Wall Street Journal: Firm Delays Muscular Dystrophy Drug U.S. Launch Amid Criticism Of $89,000 Price
In a statement posted on the website of a nonprofit group involved with muscular dystrophy, Marathon CEO Jeffrey Aronin said the company was “pausing our launch,” which had been scheduled for March. The company will meet with “caregivers and explain our commercialization plans, review their concerns, discuss all options, and move forward with commercialization based on an agreed plan of action,” he said in the statement. (Walker and Pulliam, 2/13)

The New York Times: Sharp Rise Reported In Older Americans’ Use Of Multiple Psychotropic Drugs
The number of retirement-age Americans taking at least three psychiatric drugs more than doubled between 2004 and 2013, even though almost half of them had no mental health diagnosis on record, researchers reported on Monday. The new analysis, based on data from doctors’ office visits, suggests that inappropriate prescribing to older people is more common than previously thought. Office visits are a close, if not exact, estimate of underlying patient numbers. The paper appears in the journal JAMA Internal Medicine. (Carey, 2/13)

The Washington Post: Disease ‘Superspreaders’ Accounted For Nearly Two-Thirds Of Ebola Cases, Study Finds
They are called superspreaders, the minority of people who are responsible for infecting many others during epidemics of infectious diseases. Perhaps the most famous superspreader was Typhoid Mary, presumed to have infected 51 people, three of whom died, between 1900 and 1907. Now scientists studying how Ebola spread during the 2014-2015 epidemic in West Africa say superspreaders played a bigger role than was previously known, according to findings published this week in the Proceedings of the National Academy of Sciences. (Sun, 2/13)

NPR: Scientists Inadvertently Build Cocaine-Proof Mouse
Researchers have created mice that appear impervious to the lure of cocaine. Even after the genetically engineered animals were given the drug repeatedly, they did not appear to crave it the way typical mice do, a team reports in Nature Neuroscience. (Hamilton, 2/13)

Reuters: California Lawmaker Makes Push For Health Warning Labels On Soda
A California state senator is taking another stab at introducing a law that would require sugary drink manufacturers to put a warning label on their products, the latest effort in the "War on Sugar." Officials and public health advocates have heightened their criticism of sugar as a key contributor to health epidemics like obesity and diabetes, and California has become a major battleground in the fight against what they say is excessive sugar consumption. (Prentice, 2/13)

The Associated Press: Artificial Insemination Parenting Bill Draws LGBT Criticism
Two Tennessee lawmakers want to do away with a 40-year-old state law granting legitimacy to children conceived through artificial insemination. Critics say the bill is aimed at gay couples and their children. The bill would remove a single sentence applying to child custody when artificial insemination is involved, one that’s been interpreted to make no distinction between same-sex and heterosexual couples. But opponents warn that changing the law could prevent both same-sex parents from appearing on the children’s birth certificates, affecting their ability to make parenting decisions ranging from medical care to education. (Schelzig, 2/13)

Kaiser Health News is an editorially independent operating program of the Kaiser Family Foundation. (c) 2017 Kaiser Health News. All rights reserved.

Follow us on Twitter | Facebook | LinkedIn

You are subscribed to this email alert as .

Update your email preferences to choose the types of emails you receive. Or, permanently unsubscribe from all emails.

If you need help or have questions, please send an email to subscriptions@kaiserhealthnews.org
Please do not reply to this email as this address is not monitored.

 

Kaiser Family Foundation & Kaiser Health News | 2400 Sand Hill Road | Menlo Park, CA 94025


---------------------------

All titles, content, publisher names, trademarks, artwork, and associated imagery are trademarks and/or copyright material of their respective owners. All rights reserved. The Spam Archive website contains material for general information purposes only. It has been written for the purpose of providing information and historical reference containing in the main instances of business or commercial spam.

Many of the messages in Spamdex's archive contain forged headers in one form or another. The fact that an email claims to have come from one email address or another does not mean it actually originated at that address! Please use spamdex responsibly.


Yes YOU! Get INVOLVED - Send in your spam and report offenders

Create a rule in outlook or simply forward the junk email you receive to questions@spamdex.co.uk | See contributors

Google + Spam 2010- 2017 Spamdex - The Spam Archive for the internet. unsolicited electric messages (spam) archived for posterity. Link to us and help promote Spamdex as a means of forcing Spammers to re-think the amount of spam they send us.

The Spam Archive - Chronicling spam emails into readable web records index for all time

Please contact us with any comments or questions at questions@spamdex.co.uk. Spam Archive is a non-profit library of thousands of spam email messages sent to a single email address. A number of far-sighted people have been saving all their spam and have put it online. This is a valuable resource for anyone writing Bayesian filters. The Spam Archive is building a digital library of Internet spam. Your use of the Archive is subject to the Archive's Terms of Use. All emails viewed are copyright of the respected companies or corporations. Thanks to Benedict Sykes for assisting with tech problems and Google Indexing, ta Ben.

Our inspiration is the "Internet Archive" USA. "Libraries exist to preserve society's cultural artefacts and to provide access to them. If libraries are to continue to foster education and scholarship in this era of digital technology, it's essential for them to extend those functions into the digital world." This is our library of unsolicited emails from around the world. See https://archive.org. Spamdex is in no way associated though. Supporters and members of http://spam.abuse.net Helping rid the internet of spam, one email at a time. Working with Inernet Aware to improve user knowlegde on keeping safe online. Many thanks to all our supporters including Vanilla Circus for providing SEO advice and other content syndication help | Link to us | Terms | Privacy | Cookies | Complaints | Copyright | Spam emails / ICO | Spam images | Sitemap | All hosting and cloud migration by Cloudworks.

Important: Users take note, this is Spamdex - The Spam Archive for the internet. Some of the pages indexed could contain offensive language or contain fraudulent offers. If an offer looks too good to be true it probably is! Please tread, carefully, all of the links should be fine. Clicking I agree means you agree to our terms and conditions. We cannot be held responsible etc etc.

The Spam Archive - Chronicling spam emails into readable web records

The Glass House | London | SW19 8AE |
Spamdex is a digital archive of unsolicited electronic mail 4.9 out of 5 based on reviews
Spamdex - The Spam Archive Located in London, SW19 8AE. Phone: 08000 0514541.